Rationale and design of a placebo-controlled trial to evaluate the steroid-sparing effects of anti-IL5 monoclonal antibody (mepolizumab): Focus on cutaneous outcomes in patients with hypereosinophilic syndrome (HES)

Titel:: Rationale and design of a placebo-controlled trial to evaluate the steroid-sparing effects of anti-IL5 monoclonal antibody (mepolizumab): Focus on cutaneous outcomes in patients with hypereosinophilic syndrome (HES)
Dokumenttyp:: Meeting Abstract
Autor(en):: Shear, N; Gleich, G; Leiferman, K; Ring, J
Zeitschriftentitel:: J Am Acad Dermatol
Jahr:: 2007
Band / Volume:: 56 Suppl.
Heft / Issue:: 2
Seitenangaben Beitrag:: AB71-AB71
Sprache:: eng
Print-ISSN:: 0190-9622
TUM Einrichtung:: Klinik und Poliklinik für Dermatologie und Allergologie
BibTeX

Vorkommen: